Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Endo International agrees to acquire BioSpecifics Technologies for $540m

pharmaceutical-technologyOctober 22, 2020

Tag: Endo International , BioSpecifics Technologies , acquisition

PharmaSources Customer Service